Clinical studies of novel antiviral therapies in advanced chronic hepatitis B virus infection.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/520671

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

There is an urgent need to develop therapies for treating and preventing Hepatitis B antiviral resistance, particularly in patients with advanced liver disease. Investigator-initiated clinical studies will be performed to examine a) the most effective therapy for preventing antiviral resistance and Hepatitis B recurrence following liver transplantation and b) the effect of a novel Hepatitis B antiviral, tenofovir, on multi-resistant chronic Hepetatis B infection.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2009

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $64,631.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiviral | hepatitis B | liver transplantation | prophylaxis | viral immunology

Related Links